Browsing Tag
earnings
21 posts
Why Eni SpA’s 2025 earnings may matter more in 2027 than today
Eni SpA’s 2025 earnings reveal a shift toward balance sheet strength, disciplined growth, and lower risk. Find out what changes next.
KB Home (NYSE: KBH) targets up to $6.1bn in 2026 revenue with margin-led strategy and 10% community growth
KB Home sets a 2026 revenue target of $5.1B–$6.1B with a focus on margin recovery, backlog growth, and expanding to 300 communities. Read the full analysis.
Broadcom (AVGO) delivers $18bn quarter—can AI revenue keep smashing Wall Street forecasts?
Broadcom delivers record results with soaring AI chip revenue and a 10% dividend hike. Find out why analysts call it the ultimate AI infrastructure play.
Amtech Systems (NASDAQ: ASYS) rides AI demand to Q4 comeback and launches $5m share buyback as stock surges
Find out how Amtech Systems Inc. rode the AI wave to profitability and a $5M buyback—discover what’s driving ASYS stock today!
Palo Alto Networks (NASDAQ: PANW) Q1 FY2026: Did platformization finally deliver on ARR promises?
Palo Alto Networks posts strong Q1 FY2026 earnings with 29% ARR growth and new Chronosphere acquisition. Find out how its AI-era strategy is unfolding.
Logitech (Nasdaq: LOGI) reports cybersecurity breach alongside strong Q2 FY26 earnings and maintains upbeat Q3 guidance
Logitech reports data breach and Q2 FY26 earnings beat. Find out how the tech firm balanced incident response with financial strength and forward guidance.
Can MPTI stock rally from here? Why M-tron’s $58.8m backlog is making investors take notice
M-tron Industries posts 11% YTD growth and record $58.8M backlog as it names Cameron Pforr CEO. Read the full Q3 2025 earnings analysis now.
Cisco Q1 FY26 earnings beat guidance as AI orders cross $1.5bn and campus refresh gains steam
Cisco beats Q1 FY26 estimates with $1.3B in AI orders, a robust campus refresh, and higher FY26 guidance. Find out why investors are watching closely.
Is GSK stock gearing up for a breakout? Q3 2025 results beat, guidance raised, CEO exits on a high
GSK upgrades 2025 guidance after strong Q3 results, driving a 6.57% stock surge. Find out how Specialty Medicines and Oncology powered this breakout.
Tariffs? No problem. Levi Strauss raises 2025 EPS forecast anyway
Levi Strauss raises its 2025 guidance, projecting 6% organic growth and higher EPS despite tariffs. Find out what this means for apparel investors.